HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q4 2022. The put-call ratio across all filers is 3.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $842 | +5.2% | 9,395 | 0.0% | 0.01% | +25.0% |
| Q2 2023 | $800 | +3.0% | 9,395 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $777 | +5.1% | 9,395 | 0.0% | 0.00% | -20.0% |
| Q4 2022 | $739 | -99.9% | 9,395 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $696,000 | +13.7% | 9,395 | 0.0% | 0.01% | +25.0% |
| Q2 2022 | $612,000 | +3.0% | 9,395 | 0.0% | 0.00% | +33.3% |
| Q1 2022 | $594,000 | +19.3% | 9,395 | 0.0% | 0.00% | +50.0% |
| Q4 2021 | $498,000 | -24.9% | 9,395 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $663,000 | +5.9% | 9,395 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $626,000 | -36.6% | 9,395 | +5.6% | 0.00% | -50.0% |
| Q1 2021 | $987,000 | -6.5% | 8,895 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $1,056,000 | +36.1% | 8,895 | 0.0% | 0.01% | 0.0% |
| Q3 2020 | $776,000 | -51.3% | 8,895 | -50.0% | 0.01% | -14.3% |
| Q2 2020 | $1,594,000 | – | 17,790 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BEACONLIGHT CAPITAL, LLC | 95,033 | $8,511,000 | 2.84% |
| Advantage Alpha Capital Partners LP | 100,170 | $8,971,000 | 2.10% |
| Nitorum Capital, L.P. | 395,635 | $35,433,000 | 1.82% |
| Summit Creek Advisors LLC | 127,600 | $11,428,000 | 1.68% |
| Bridge City Capital, LLC | 40,559 | $3,632,000 | 1.67% |
| AEGON ASSET MANAGEMENT UK PLC | 520,408 | $46,603,000 | 1.05% |
| Jackson Square Partners, LLC | 2,298,190 | $205,825,000 | 1.03% |
| Parkman Healthcare Partners LLC | 30,147 | $2,700,000 | 0.76% |
| TEALWOOD ASSET MANAGEMENT INC | 9,154 | $820,000 | 0.54% |
| AMERICAN CAPITAL MANAGEMENT INC | 159,145 | $14,253,000 | 0.52% |